ETHERNA IMMUNOTHERAPIES (Public limited company)
ETHERNA IMMUNOTHERAPIES is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0502.703.389. It was founded on 21-01-2013. Its registered office is in Niel. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -3 907 881 and a loss of € 4 271 721. These accounts report 52.1 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 09-10-2026.
Company information
Key figures of ETHERNA IMMUNOTHERAPIES
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -4 271 721+36 % | € -6 623 923+38 % | € -10 679 614+42 % | € -18 453 870 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -3 907 881 | € 349 455-95 % | € 6 973 378-60 % | € 17 652 992 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 12 757 962-15 % | € 15 065 113-6 % | € 16 006 045-36 % | € 25 049 496 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | - | - | - | - |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 52.1-25 % | 69.9+2 % | 68.6+7 % | 64.1 |
Financial estimate
- 3 Shareholders
- 1 Subsidiaries
- 5 Board links
Similar companies
Other companies in the same activity in Niel.
| Company | Town |
|---|---|
| OXYPOINT | 2845 Niel |
| Clinical Projects International | 2845 Niel |
| iFLUX | 2845 Niel |
| anicells | 2845 Niel |
| GRAND MEDICAL (EUROPE) | 2845 Niel |
| SYNAPTIX | 2845 Niel |
| ImmuneSpec | 2845 Niel |
| EUROPEAN RESPIRATORY CLUSTER ANTWERP | 2845 Niel |
Frequently asked questions
Is ETHERNA IMMUNOTHERAPIES still active? Yes. The Crossroads Bank for Enterprises lists ETHERNA IMMUNOTHERAPIES as active.
What is the VAT number of ETHERNA IMMUNOTHERAPIES? The VAT number of ETHERNA IMMUNOTHERAPIES is BE 0502.703.389.
When was ETHERNA IMMUNOTHERAPIES founded? ETHERNA IMMUNOTHERAPIES was founded on 21-01-2013.
What is the address of ETHERNA IMMUNOTHERAPIES? The current registered office of ETHERNA IMMUNOTHERAPIES is Galileilaan 19, 2845 Niel.
When did ETHERNA IMMUNOTHERAPIES last file annual accounts? The latest annual accounts of ETHERNA IMMUNOTHERAPIES were filed on 29-05-2026.
Does ETHERNA IMMUNOTHERAPIES file its annual accounts on time? Yes. ETHERNA IMMUNOTHERAPIES filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does ETHERNA IMMUNOTHERAPIES have? ETHERNA IMMUNOTHERAPIES employs 52.1 full-time equivalents according to its most recent annual accounts.
Is ETHERNA IMMUNOTHERAPIES financially healthy? Addrly gives ETHERNA IMMUNOTHERAPIES a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is ETHERNA IMMUNOTHERAPIES profitable? The annual accounts of ETHERNA IMMUNOTHERAPIES for 2025 show a loss of € 4 271 721.
What is the equity of ETHERNA IMMUNOTHERAPIES? The equity of ETHERNA IMMUNOTHERAPIES was € -3 907 881 at the close of the 2025 financial year.
Who are the directors of ETHERNA IMMUNOTHERAPIES? The annual accounts of ETHERNA IMMUNOTHERAPIES record 19 mandates. The names, roles and dates are visible with a free account.
Can ETHERNA IMMUNOTHERAPIES receive Peppol e-invoices? Yes. ETHERNA IMMUNOTHERAPIES is registered on the Peppol network and can receive structured electronic invoices.
What does ETHERNA IMMUNOTHERAPIES do? The main activity of ETHERNA IMMUNOTHERAPIES is: Scientific research and development.